| - GRCh37:
- Chr1:201328344
- GRCh38:
- Chr1:201359216
| TNNT2 | W287*, W294*, W284*, W281*, W254*, W297* | Hypertrophic cardiomyopathy, not provided, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy 2, Cardiovascular phenotype
| Pathogenic/Likely pathogenic (Sep 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201328345
- GRCh38:
- Chr1:201359217
| TNNT2 | W287*, W294*, W281*, W284*, W254*, W297* | Cardiovascular phenotype, not provided, Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Cardiomyopathy, Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 2, Hypertrophic cardiomyopathy
| Pathogenic/Likely pathogenic (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201328750
- GRCh38:
- Chr1:201359622
| TNNT2 | | Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy 2 | Pathogenic/Likely pathogenic (Jul 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201328750
- GRCh38:
- Chr1:201359622
| TNNT2 | | Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy | Pathogenic/Likely pathogenic (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201328750
- GRCh38:
- Chr1:201359622
| TNNT2 | | Cardiovascular phenotype, Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Cardiomyopathy, Hypertrophic cardiomyopathy
| Pathogenic/Likely pathogenic (Sep 16, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201328755
- GRCh38:
- Chr1:201359627
| TNNT2 | K273E, K280E, K283E, K240E, K267E, K270E | not provided | Pathogenic (Sep 28, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201328757-201328758
- GRCh38:
- Chr1:201359629-201359630
| TNNT2 | Q282fs, Q266fs, Q269fs, Q272fs, Q279fs, Q239fs | Cardiomyopathy | Pathogenic (Sep 11, 2013) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201328765
- GRCh38:
- Chr1:201359637
| TNNT2 | N269K, N276K, N236K, N263K, N266K, N279K | Cardiovascular phenotype | Likely pathogenic (Aug 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201330450
- GRCh38:
- Chr1:201361322
| TNNT2 | E246G, E253G, E240G, E243G, E256G, E213G | not provided | Likely pathogenic (Mar 8, 2012) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201331039
- GRCh38:
- Chr1:201361911
| TNNT2 | | not provided | Likely pathogenic (Sep 16, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr1:201331098
- GRCh38:
- Chr1:201361970
| TNNT2 | I211T, I218T, I178T, I205T, I208T, I221T | Hypertrophic cardiomyopathy 2 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr1:201331099-201331101
- GRCh38:
- Chr1:201361971-201361973
| TNNT2 | K210del, K217del, K177del, K204del, K207del, K220del | Cardiovascular phenotype, not provided, Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Cardiomyopathy, Primary dilated cardiomyopathy, Dilated cardiomyopathy 1D, Hypertrophic cardiomyopathy 2
| Pathogenic/Likely pathogenic (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201331116
- GRCh38:
- Chr1:201361988
| TNNT2 | R205L, R212L, R202L, R172L, R199L, R215L | Dilated cardiomyopathy 1D | Pathogenic (Nov 16, 2004) | no assertion criteria provided |
| - GRCh37:
- Chr1:201331122
- GRCh38:
- Chr1:201361994
| TNNT2 | T203S, T170S, T200S, T210S, T213S, T197S | Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3
| Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201331143
- GRCh38:
- Chr1:201362015
| TNNT2 | R190L, R163L, R191L, R195L, R206L, R193L, R196L, R203L | Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy 2
| Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201331151
- GRCh38:
- Chr1:201362023
| TNNT2 | | not provided | Likely pathogenic (Mar 4, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201331512
- GRCh38:
- Chr1:201362384
| TNNT2 | | Hypertrophic cardiomyopathy 2 | Likely pathogenic (Feb 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201331513
- GRCh38:
- Chr1:201362385
| TNNT2 | | not provided | Likely pathogenic (Apr 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201332458
- GRCh38:
- Chr1:201363330
| TNNT2 | S179F, S189F, S149F, S174F | Cardiovascular phenotype, Hypertrophic cardiomyopathy 2, Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3
| Pathogenic/Likely pathogenic (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201332459
- GRCh38:
- Chr1:201363331
| TNNT2 | S179A, S189A, S149A, S174A | Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3
| Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201332476
- GRCh38:
- Chr1:201363348
| TNNT2 | R143L, R168L, R173L, R183L | Dilated cardiomyopathy 1D | Pathogenic (Jul 18, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201332476
- GRCh38:
- Chr1:201363348
| TNNT2 | R173Q, R183Q, R143Q, R168Q | Cardiovascular phenotype, not provided, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy 2, Primary dilated cardiomyopathy
| Pathogenic/Likely pathogenic (Aug 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201332477
- GRCh38:
- Chr1:201363349
| TNNT2 | R173W, R183W, R143W, R168W | Cardiovascular phenotype, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Primary dilated cardiomyopathy, not provided | Pathogenic (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201332498
- GRCh38:
- Chr1:201363370
| TNNT2 | R166G, R176G, R136G, R161G | not provided | Likely pathogenic (Feb 28, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201332505-201332507
- GRCh38:
- Chr1:201363377-201363379
| TNNT2 | E163del, E173del, E133del, E158del | Cardiovascular phenotype, not provided, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy 2, Hypertrophic cardiomyopathy
| Pathogenic/Likely pathogenic (Oct 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201332525
- GRCh38:
- Chr1:201363397
| TNNT2 | A127P, A152P, A157P, A167P | Hypertrophic cardiomyopathy 2 | Likely pathogenic (Nov 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201333464
- GRCh38:
- Chr1:201364336
| TNNT2 | R141W, R151W, R111W, R136W | Familial isolated dilated cardiomyopathy, Hypertrophic cardiomyopathy, Primary dilated cardiomyopathy, not provided, Dilated cardiomyopathy 1D, Hypertrophic cardiomyopathy 2, Cardiomyopathy, familial restrictive, 3, Cardiomyopathy, Dilated cardiomyopathy 1D
| Pathogenic (Jan 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201333470
- GRCh38:
- Chr1:201364342
| TNNT2 | R134G, R149G, R138G, R109G, R139G | Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3
| Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201333470
- GRCh38:
- Chr1:201364342
| TNNT2 | R139S, R149S, R109S, R134S | not provided | Likely pathogenic (Sep 17, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201333485
- GRCh38:
- Chr1:201364357
| TNNT2 | R134G, R144G, R129G, R104G | Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Primary dilated cardiomyopathy | Pathogenic/Likely pathogenic (Apr 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201333493
- GRCh38:
- Chr1:201364365
| TNNT2 | R131P, R141P, R126P, R101P | Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Primary dilated cardiomyopathy | Likely pathogenic (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201333493
- GRCh38:
- Chr1:201364365
| TNNT2 | R131Q, R141Q, R101Q, R126Q | not provided, Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Primary dilated cardiomyopathy | Pathogenic (Mar 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201333494
- GRCh38:
- Chr1:201364366
| TNNT2 | R131G, R141G, R101G, R126G | not provided | Likely pathogenic (Sep 7, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201333494
- GRCh38:
- Chr1:201364366
| TNNT2 | R131W, R141W, R126W, R101W | Cardiovascular phenotype, not provided, Dilated cardiomyopathy 1D, Hypertrophic cardiomyopathy 2, Cardiomyopathy, familial restrictive, 3, Primary dilated cardiomyopathy
| Pathogenic/Likely pathogenic (Oct 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201333497
- GRCh38:
- Chr1:201364369
| TNNT2 | R130C, R140C, R125C, R100C | Cardiovascular phenotype, not provided, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy 2, Cardiomyopathy, Hypertrophic cardiomyopathy 2, Hypertrophic cardiomyopathy | Pathogenic/Likely pathogenic (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201334345
- GRCh38:
- Chr1:201365217
| TNNT2 | E114Q, E119Q, E129Q | Primary familial dilated cardiomyopathy | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334348
- GRCh38:
- Chr1:201365220
| TNNT2 | E118K, E128K, E113K | Primary dilated cardiomyopathy | Likely pathogenic (Jan 14, 2013) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334370
- GRCh38:
- Chr1:201365242
| TNNT2 | F110L, F120L, F105L | Hypertrophic cardiomyopathy, Wolff-Parkinson-White pattern, not provided, Primary familial hypertrophic cardiomyopathy | Pathogenic/Likely pathogenic (Nov 27, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201334372
- GRCh38:
- Chr1:201365244
| TNNT2 | F110L, F120L, F105L | not provided | Likely pathogenic (Feb 21, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr1:201334372
- GRCh38:
- Chr1:201365244
| TNNT2 | F110I, F120I, F105I | Cardiomyopathy, Dilated cardiomyopathy 1D | Pathogenic (Mar 4, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201334375-201334376
- GRCh38:
- Chr1:201365247-201365248
| TNNT2 | H104Y, H109Y, H119Y | Primary dilated cardiomyopathy | Likely pathogenic (Nov 16, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334381
- GRCh38:
- Chr1:201365253
| TNNT2 | E107*, E117*, E102* | not provided | Pathogenic (Mar 8, 2012) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334397-201334402
- GRCh38:
- Chr1:201365269-201365274
| TNNT2 | | Primary familial hypertrophic cardiomyopathy | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334409
- GRCh38:
- Chr1:201365281
| TNNT2 | K96N, K97N, K107N, K92N | Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3
| Pathogenic (Feb 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334409
- GRCh38:
- Chr1:201365281
| TNNT2 | K107N, K97N, K92N | not provided, Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy | Pathogenic/Likely pathogenic (May 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201334412-201334414
- GRCh38:
- Chr1:201365284-201365286
| TNNT2 | E106del, E96del, E91del | Hypertrophic cardiomyopathy | Likely pathogenic (Mar 1, 2008) | no assertion criteria provided |
| - GRCh37:
- Chr1:201334419
- GRCh38:
- Chr1:201365291
| TNNT2 | R104L, R94L, R89L | Cardiovascular phenotype, Dilated cardiomyopathy 1D, Hypertrophic cardiomyopathy 2, not provided, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy 2, Hypertrophic cardiomyopathy | Pathogenic/Likely pathogenic (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201334419
- GRCh38:
- Chr1:201365291
| TNNT2 | R104H, R94H, R89H | Cardiovascular phenotype, not provided, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy 2, Hypertrophic cardiomyopathy
| Pathogenic (Aug 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201334420
- GRCh38:
- Chr1:201365292
| TNNT2 | R104C, R94C, R89C | Cardiovascular phenotype, not provided, Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Restrictive cardiomyopathy, Primary familial hypertrophic cardiomyopathy | Pathogenic/Likely pathogenic (Apr 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201334423
- GRCh38:
- Chr1:201365295
| TNNT2 | K103Q, K93Q, K88Q | Hypertrophic cardiomyopathy | Likely pathogenic (Oct 31, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334425
- GRCh38:
- Chr1:201365297
| TNNT2 | R102L, R92L, R87L | not provided | Pathogenic (Jan 18, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr1:201334425
- GRCh38:
- Chr1:201365297
| TNNT2 | R92Q, R102Q, R87Q | Cardiovascular phenotype, not provided, Dilated cardiomyopathy 1D, Hypertrophic cardiomyopathy 2, Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy 2, Hypertrophic cardiomyopathy | Pathogenic/Likely pathogenic (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201334426
- GRCh38:
- Chr1:201365298
| TNNT2 | R102W, R92W, R87W | Cardiovascular phenotype, not provided, Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 2, Hypertrophic cardiomyopathy | Pathogenic (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201334431
- GRCh38:
- Chr1:201365303
| TNNT2 | I100N, I85N, I90N | Hypertrophic cardiomyopathy 2 | Likely pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334436
- GRCh38:
- Chr1:201365308
| TNNT2 | | TNNT2-related disorder | Likely pathogenic (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334738
- GRCh38:
- Chr1:201365610
| TNNT2 | D97E, D98E, D83E, D88E | Primary dilated cardiomyopathy | Likely pathogenic (May 14, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334738
- GRCh38:
- Chr1:201365610
| TNNT2 | D88E, D98E, D97E, D83E | Primary dilated cardiomyopathy | Likely pathogenic (Jun 4, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334742
- GRCh38:
- Chr1:201365614
| TNNT2 | F86Y, F96Y, F87Y, F82Y, F97Y | Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3
| Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334742
- GRCh38:
- Chr1:201365614
| TNNT2 | F87C, F96C, F97C, F82C, F86C | Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3
| Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334745
- GRCh38:
- Chr1:201365617
| TNNT2 | D86A, D96A, D81A, D95A | Cardiovascular phenotype, not provided, Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D, Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy
| Pathogenic/Likely pathogenic (Mar 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201334749
- GRCh38:
- Chr1:201365621
| TNNT2 | V94M, V85M, V80M, V95M | Cardiomyopathy, familial restrictive, 3, Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D
| Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334758
- GRCh38:
- Chr1:201365630
| TNNT2 | G82R, G92R, G77R, G91R | not provided, Hypertrophic cardiomyopathy | Pathogenic/Likely pathogenic (Mar 30, 2016) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201334763
- GRCh38:
- Chr1:201365635
| TNNT2 | P80L, P90L, P75L, P89L | not provided | Pathogenic (Oct 14, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201334766
- GRCh38:
- Chr1:201365638
| TNNT2 | I79N, I89N, I74N, I88N | Cardiovascular phenotype, not provided, Dilated cardiomyopathy 1D, Hypertrophic cardiomyopathy 2, Cardiomyopathy, familial restrictive, 3, Cardiomyopathy, Hypertrophic cardiomyopathy | Pathogenic (Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201338975
- GRCh38:
- Chr1:201369847
| TNNT2 | | Dilated cardiomyopathy 1D | Likely pathogenic (Feb 1, 2013) | criteria provided, single submitter |
| | TNNT2 | | Cardiomyopathy, familial restrictive, 3 | Pathogenic (Jan 25, 2008) | no assertion criteria provided |